A peptide fragment of histone H3
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Histone H3 (1-15) (Phospho-Ser10) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt)

Item No. 27494

Technical Information
Formal Name
N-L-alanyl-L-arginyl-L-threonyl-L-lysyl-L-glutaminyl-L-threonyl-L-alanyl-L-arginyl-L-lysyl-O-phosphono-L-seryl-L-threonylglycylglycyl-L-lysyl-L-alanine, trifluoroacetate salt
Synonyms
  • ARTKQTARK-pS-TGGKA
  • [pSer10]-Histone H3 (1-15)
  • 1-15 H3pS10
  • H3S10ph (1-15)
  • H31-15S10ph
Molecular Formula
C63H118N25O24P • XCF3COOH
Formula Weight
Purity
≥95%
A solid
Water: 1 mg/ml
SMILES
O=C(O)C(F)(F)F.C[C@@H](O)[C@@]([H])(C(NCC(NCC(N[C@H](C(N[C@@H](C)C(O)=O)=O)CCCCN)=O)=O)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](C)NC([C@@]([H])(NC([C@@H](NC([C@@H](NC([C@@]([H])(NC([C@@H](NC([C@H](C)N)=O)CCCNC(N)=N)=O)[C@H](O)C)=O)CCCCN)=O)CCC(N)=O)=O)[C@H](O)C)=O)=O)CCCNC(N)=N)=O)CCCCN)=O)COP(O)(O)=O)=O
InChi Code
InChI=1S/C63H118N25O24P.C2HF3O2/c1-30(67)49(95)80-40(19-14-26-74-63(71)72)55(101)88-48(35(6)91)60(106)84-38(17-9-12-24-66)52(98)83-41(20-21-43(68)92)56(102)87-47(34(5)90)59(105)77-31(2)50(96)81-39(18-13-25-73-62(69)70)53(99)82-37(16-8-11-23-65)54(100)85-42(29-112-113(109,110)111)57(103)86-46(33(4)89)58(104)76-27-44(93)75-28-45(94)79-36(15-7-10-22-64)51(97)78-32(3)61(107)108;3-2(4,5)1(6)7/h30-42,46-48,89-91H,7-29,64-67H2,1-6H3,(H2,68,92)(H,75,93)(H,76,104)(H,77,105)(H,78,97)(H,79,94)(H,80,95)(H,81,96)(H,82,99)(H,83,98)(H,84,106)(H,85,100)(H,86,103)(H,87,102)(H,88,101)(H,107,108)(H4,69,70,73)(H4,71,72,74)(H2,109,110,111);(H,6,7)/t30-,31-,32-,33+,34+,35+,36-,37-,38-,39-,40-,41-,42-,46-,47-,48-;/m0./s1
InChi Key
BGYUIWIBNPSWOU-GJIGDEGVSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Product Description

    Histone H3 (1-15) (phospho-Ser10) is a peptide fragment that corresponds to amino acid residues 2-16 of the human histone H3 sequence. Phosphorylation of histone H3 at serine 10 is correlated with chromatin condensation during mitosis and with transcriptional activation of genes during interphase.1,2 Histone H3 (1-15) (phospho-Ser10) does not inhibit binding of the ADD domain of the chromatin-remodeling protein ATRX to histone H3 due to its positioning away from the core peptide binding sequence but does decrease binding of the HP1α chromodomain (CD) when histone H3 is also methylated at lysine 9.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Sawicka, A., and Seiser, C. Histone H3 phosphorylation - A versatile chromatin modification for different occasions. Biochimie 94(11), 2193-2201 (2012).

    2. Prigent, C., and Dimitrov, S. Phosphorylation of serine 10 in histone H3, what for? J. Cell. Sci. 116(Pt. 18), 3677-3685 (2003).

    3. Noh, K.M., Maze, I., Zhao, D., et alATRX tolerates activity-dependent histone H3 methyl/phos switching to maintain repetitive element silencing in neurons. Proc. Natl. Acad. Sci. USA 112(22), 6820-6827 (2015).